Main > NEUROLOGY. > CH. R. SMA>Treat.>SMN2 Splicing>
CH. R. SMA>Treat.>SMN2 Splicing>'s subsections
(*) CA Approval Date: 2021. 04.15
(*) EU Approval Date: 2021. 03.30
(*) USA Approval Date: 2020. 08.07.
>Modifier
Company
Company Licensee CA
Company Licensee USA
Generic Name: Risdiplam
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2021. 12.21
RTM
RTM Web-Site USA
SMN: Survival Motor Neuron
CH. R. SMA>Treat.>SMN2 Splicing>'s products
This section has no products